- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 28 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 6 residues within 4Å:- Chain A: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.3: 4 residues within 4Å:- Chain A: T.63, G.64, Q.440
- Chain C: K.473
Ligand excluded by PLIPSO4.4: 4 residues within 4Å:- Chain A: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.5: 5 residues within 4Å:- Chain A: Y.11, W.348, E.349, Q.350, R.353
Ligand excluded by PLIPSO4.6: 3 residues within 4Å:- Chain A: R.44, S.465, Y.487
Ligand excluded by PLIPSO4.7: 3 residues within 4Å:- Chain A: E.254, R.257
- Chain B: K.441
Ligand excluded by PLIPSO4.8: 2 residues within 4Å:- Chain A: H.290, K.293
Ligand excluded by PLIPSO4.9: 2 residues within 4Å:- Chain A: R.44, S.45
Ligand excluded by PLIPSO4.11: 7 residues within 4Å:- Chain A: S.242
- Chain B: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.12: 4 residues within 4Å:- Chain B: G.193, K.194, S.242, G.243
Ligand excluded by PLIPSO4.13: 4 residues within 4Å:- Chain B: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.14: 5 residues within 4Å:- Chain B: Q.226, T.272, H.273, N.275, V.276
Ligand excluded by PLIPSO4.15: 2 residues within 4Å:- Chain B: R.44, S.45
Ligand excluded by PLIPSO4.16: 3 residues within 4Å:- Chain B: R.44, S.465, Y.487
Ligand excluded by PLIPSO4.17: 3 residues within 4Å:- Chain B: R.277, V.305, H.306
Ligand excluded by PLIPSO4.19: 4 residues within 4Å:- Chain A: K.473
- Chain C: T.63, G.64, Q.440
Ligand excluded by PLIPSO4.20: 6 residues within 4Å:- Chain C: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.21: 4 residues within 4Å:- Chain C: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.22: 4 residues within 4Å:- Chain C: Y.11, E.349, Q.350, R.353
Ligand excluded by PLIPSO4.23: 2 residues within 4Å:- Chain C: E.254, R.257
Ligand excluded by PLIPSO4.24: 2 residues within 4Å:- Chain C: R.44, S.45
Ligand excluded by PLIPSO4.25: 2 residues within 4Å:- Chain C: R.44, Y.487
Ligand excluded by PLIPSO4.27: 7 residues within 4Å:- Chain C: S.242
- Chain D: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.28: 4 residues within 4Å:- Chain D: G.193, K.194, S.242, G.243
Ligand excluded by PLIPSO4.29: 4 residues within 4Å:- Chain D: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.30: 2 residues within 4Å:- Chain D: R.44, S.45
Ligand excluded by PLIPSO4.31: 5 residues within 4Å:- Chain D: Q.226, T.272, H.273, N.275, V.276
Ligand excluded by PLIPSO4.32: 3 residues within 4Å:- Chain D: R.44, S.465, Y.487
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lieberman, R.L. et al., Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability. Biochemistry (2009)
- Release Date
- 2009-05-05
- Peptides
- Glucosylceramidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
SMTL ID : 3gxm.2 (3 other biounits)
Crystal structure of acid-beta-glucosidase at pH 4.5, phosphate crystallization condition
Glucosylceramidase
Toggle Identical (ABCD)Related Entries With Identical Sequence
1ogs.1 | 1ogs.2 | 1y7v.1 | 1y7v.2 | 1y7v.3 | 1y7v.4 | 1y7v.5 | 1y7v.6 | 2f61.1 | 2f61.2 | 2j25.1 | 2j25.2 | 2nsx.1 | 2nsx.2 | 2nsx.3 | 2nsx.4 | 2nsx.5 | 2nsx.6 | 2nsx.7 | 2nsx.8 | 2nsx.9 | 2nt0.1 | 2nt0.2 | 2nt0.3 | 2nt0.4 | 2nt1.1 | 2nt1.2 | 2nt1.3 | 2nt1.4 | 2nt1.5 more...less...3gxd.1 | 3gxf.1 | 3gxf.2 | 3gxi.1 | 3gxi.2 | 3gxi.3 | 3gxi.4 | 3gxm.1 | 3gxm.3 | 3gxm.4 | 3rik.1 | 3rik.2 | 3ril.1 | 3ril.2 | 6moz.1 | 6moz.2 | 6q1n.1 | 6q1n.2 | 6q1p.1 | 6q1p.2 | 6q1p.3 | 6q6k.1 | 6q6l.1 | 6q6n.1 | 6tjj.1 | 6tjj.2 | 6ytp.1 | 6ytp.2 | 6yut.1 | 6yut.2 | 6yv3.1 | 6yv3.2 | 6z39.1 | 8p3e.1 | 8p41.1 | 8p41.2